Skip to content
DefDex

Federal award

ABBOTT RAPID DX NORTH AMERICA LLC

SPE2DE21F0150

Contract

Obligated and Ceiling

Obligated (net)
$89,832,659.48
Ceiling (potential value, not spending)
$89,832,659.48
Current value
$89,832,659.48
Gross positive obligations
$90,606,977.70

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
ABBOTT RAPID DX NORTH AMERICA LLC · P782RNU1NNK3
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
ABBOTT LABORATORIES · EF9EAJ1MF6U3
Awarding agency
Department of War · sub-agency 97AS · office SPE2DE
Funding agency
Department of War · sub-agency 97AS
Product or service (PSC)
6640 · LABORATORY EQUIPMENT AND SUPPLIES
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
SPE2DE21F0150
Parent vehicle (IDV PIID)
SPE2DE20D0027
Award type code
C
Actions
7 · Dec 30, 2020 to May 12, 2021
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History7

Award actions
DateFYModAction typeObligationCompany in company totals
May 12, 2021FY2021P00006D−$774,318.22
—
Feb 9, 2021FY2021P00005B$0.00
—
Feb 3, 2021FY2021P00004M$0.00
—
Jan 28, 2021FY2021P00003M$0.00
—
Jan 19, 2021FY2021P00002M$0.00
—
Jan 8, 2021FY2021P00001M$0.00
—
Dec 30, 2020FY20210—$90,606,977.70
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.